Dual-PhD Formulation Engineering · Beijing & Suzhou

Cosmetic Peptide & Transdermal Carrier Formulation Project Support

When a skincare or scalp project involves multi-active compatibility, true net-peptide concentration auditing, or choosing between neat raw powder, AHPX+ liquid delivery complex, bulk kg/liter bases, and phased custom-packaged ODM, our R&D team bridges molecular chemistry and ISO 22716 manufacturing.

Formulation Compatibility Matrix

Four Common Multi-Active Failure Modes We Prevent Before Scale-Up

Co-developed by Dr. Yiqiong Ji’s Taicang formulation laboratory and Dr. Libo Du’s Beijing molecular advisory team.

Cosmetic peptide formulation compatibility challenges and WUMO / Suzhou Xilin engineering solutions
Target Formula System Typical Bench / Factory Failure Mode WUMO & Suzhou Xilin Formulation Architecture
Copper Tripeptide-1 (GHK-Cu) Serums, Mists & Creams Low pH (<4.5), L-ascorbic acid, strong alpha-hydroxy acids, EDTA, or caprylhydroxamic acid strip Cu²⁺ from the GHK tripeptide—turning royal-blue formulas green/brown or precipitating copper. Formulate inside pH 5.5–6.8 using non-chelating diol/hydroxyacetophenone preservation, pairing true net-active GHK-Cu with Ectoin, Panthenol, cross-linked hyaluronate, and Suzhou Xilin’s patent-pending antioxidant stabilization system (CN120753979A).
Acetyl Hexapeptide-8 + High-Acid / Niacinamide “Glass-Skin” Hybrids Hydrophilic hexapeptide (>800 Da) exhibits poor passive stratum corneum permeation, while unbuffered glycolic acid (<pH 3.5) hydrolyzes peptide bonds and converts niacinamide to irritating nicotinic acid. Deploy patent-pending AHPX+ modified-chitosan delivery complex (CN120248173A, +219% 8h permeation) alongside buffered PHA (lactobionic acid / gluconolactone) + niacinamide at pH 4.8–5.5, added at ≤45 °C.
Multi-Peptide Hydrogel Masks & High-Pro-Xylane Eye/Face Creams Charged peptides and sulfated marine polysaccharides (e.g., fucoidan) trigger hydrogel syneresis (water weeping), while high-load Pro-Xylane (30%–50% raw input) causes tackiness and emulsion phase separation. Apply an electrolyte-tolerant hydrogel base paired with Suzhou Xilin’s patent-pending synergistic peptide composition (CN120549802A) for clean peel-off tensile strength, and lamellar liquid-crystal emulsification within our ISO 22716 eye-care certified scope.
Leave-On Scalp Serums & Follicle Microbiome Cleansers Diaminopyrimidine Oxide (Aminexil) recrystallizes in cold water, and crystalline L-menthol requires high ethanol that stings sensitive scalps. Co-solubilize verified Diaminopyrimidine Oxide with amphiphilic Menthol Citrate Ester and GHK-Cu in low-ethanol aqueous/glycol vehicles.

Project Routing

Choose the Right Supply Path After Technical Alignment

Whether your brand compounds in-house in Europe/North America or needs turnkey export filling in China, our technical review routes directly into execution.

Path B · Bulk Semi-Finished Bases (Kg / L)

For Local Bottling & Clinic Groups

Receive fully compounded, QC-released peptide serums, eye/face emulsions, or soothing mists in sealed 1 kg–25 kg export drums from Suzhou Xilin (ISO 22716:2007)—ready for local filling into your domestic packaging without bottle freight or mold delays.

Path C · Phased Custom-Packaged ODM

For Turnkey Private-Label Brands

Transition from custom bench sampling under NNN/NDA into phased split-batch filling at Suzhou Xilin—including eye-care certified GMP scope and EU PIF/CPSR, UK SCPN, US MoCRA, and ANVISA manufacturer dossiers.

Laboratory & Carrier Briefs

Watch Transdermal Carrier, Solubility & Formulation Walkthroughs

Review verified technical briefings on AHPX+ chitosan permeation, Acetyl Hexapeptide-8 solubility, GHK-Cu stability, and Suzhou Xilin’s formulation lab.

Open Full Video Evidence Library (8 Videos) →
Company & Production Site Documentary2:55

On-Site Documentary · Taicang, Suzhou · 2:55

Suzhou Xilin Biotechnology (苏州汐霖生物科技有限公司): R&D, Cleanroom Production & Founder Profile

Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.

Verification scope:Registered exhibitor & production entity (苏州汐霖生物科技有限公司), R&D lab & 600 m² cleanroom
Jump to timestamp:

Key Verifiable Points & Parameters

  • Entity & Location: 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.), founded in 2021 in Taicang, Suzhou, Jiangsu, China.
  • Founder & R&D Leadership: Dr. Yiqiong Ji (纪艺琼 / Dr. Kee), with 20 years of research experience in nanomedicine and transdermal active-ingredient delivery across the skin barrier.
  • Cleanroom & Equipment: 600 m² of controlled cleanroom production space, laminar flow benches, overhead formulation mixers, stainless-steel cosmetic emulsifying/homogenizing reactors, packaging lines, and warehouse dispatch.
  • Facility Scope: Covers cosmetic formulation R&D, transdermal delivery systems, and ISO 22716 cosmetic GMP production at Suzhou Xilin.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.

Verbatim Audio / Visual Transcript:Narrator: At Taicang Port (太仓港区), an entrepreneur with a research background at the Chinese Academy of Sciences spent 20 years studying how to improve the delivery of active ingredients across the skin barrier. Then came another four years of turning that research into a real business. Title card: How many skin barriers must skincare ingredients penetrate to be fully absorbed? Dr. Yiqiong Ji (纪艺琼, Founder of 苏州汐霖生物科技有限公司 / Suzhou Xilin Biotechnology Co., Ltd.): "My name is Yiqiong Ji. I founded Suzhou Xilin Biotech in Taicang in 2021. My background is nanomedicine delivery research, essentially helping active ingredients work where they are needed. We apply this knowledge to cosmetics, improving skincare active delivery. Our facility includes 600 m² of cleanroom space, ensuring traceability. Brands choose us for our technical capabilities. For a tech-driven team, R&D, production, and market opening are challenges." Partner commentary: "Support, like a well-designed delivery system, works quietly beneath the surface. We want to be a dependable partner to growing businesses. Ms. Ji’s team remains focused on technology and approaches its work with discipline. Through professional and efficient financial services, we help them concentrate on R&D and production. This gives the company greater stability and confidence as it grows." Dr. Yiqiong Ji: "Our goal is to make advanced technology accessible, enabling brands to benefit from high-quality R&D. Quality, reliable performance, and accessible pricing are our focus. Last year, we successfully launched a cream featuring hydroxypropyl tetrahydropyrantriol (Pro-Xylane) and other products, which were well received. This year we aim to integrate new technologies and ideas for stronger product performance." Partner commentary: "Taicang Port is home to many technology-driven companies like Suzhou Xilin Biotech. They stay focused, develop their expertise, and grow steadily." Dr. Yiqiong Ji: "We are planning our layered Precision Age Care series using a layer-specific skincare approach. It combines our delivery technology with actives to address various signs of aging and skin needs. This multi-level system targets hydration, barrier care, firmness, elasticity, and smoother skin. Each formula addresses a defined concern, reflecting our core principle: precision in formulation design and active ingredient delivery." Narrator: "Research and company building take time, but with sound technology and reliable materials, their value becomes visible."

Editorial & Verification Scope Note:Note on AI English dubbing captions: The video’s burned-in English captions phonetically render 太仓 (Taicang) as "Tai Cheng / Taichung" and 汐霖 (Xilin) as "Silan / Xylan Biotech". The on-screen Chinese signage at 01:04 shows the official registered name: 苏州汐霖生物科技有限公司 (SUZHOU XILIN BIOTECHNOLOGY CO., LTD).

Cosmetic Peptide Specification Brief0:55

Specification & Formulation Brief · CAS 616204-22-9 · 0:55

Acetyl Hexapeptide-8 (CAS 616204-22-9): Raw Material Specifications, Water Solubility & 56-Day Study

Specification and formulation walkthrough for Acetyl Hexapeptide-8 (CAS 616204-22-9, MW 889.01): aqueous dissolution demonstration, typical raw-material specification parameters (Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/mL in H2O), recommended formulation range (100–1,000 ppm, pH 3–8), and 56-day topical test solution study on 17 women.

Verification scope:INCI Acetyl Hexapeptide-8 specifications, aqueous solubility & 56-day topical test data
Jump to timestamp:

Key Verifiable Points & Parameters

  • Identity & Analytical Specs: INCI Acetyl Hexapeptide-8, CAS 616204-22-9, Molecular Weight 889.01 Da, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Aqueous Solubility ≥5 mg/mL (H2O).
  • Formulation Guidelines: Water-soluble white to off-white powder; suggested use level 100–1,000 ppm (0.01%–0.1%) at formulation pH 3–8; store cool and dry (-5 to 8 °C, 2-year shelf life).
  • 56-Day Topical Study (n = 17 women): Using a 0.05% (500 ppm) test solution twice daily across Day 0, 14, 28, and 56.
  • Measured Day 56 Outcomes vs Baseline: Facial line volume -21.92% and facial line area -21.51% in the supplier-recorded topical study.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Specification and formulation walkthrough for Acetyl Hexapeptide-8 (CAS 616204-22-9, MW 889.01): aqueous dissolution demonstration, typical raw-material specification parameters (Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/mL in H2O), recommended formulation range (100–1,000 ppm, pH 3–8), and 56-day topical test solution study on 17 women.

Verbatim Audio / Visual Transcript:Meet Acetyl Hexapeptide-8, a cosmetic peptide for fine-line care. This water-soluble ingredient is designed for topical skincare formulas. Specification summary: INCI Acetyl Hexapeptide-8, CAS No. 616204-22-9, Appearance white to off-white powder, Mass spec MW 889.01, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/ml (H2O), Pack size 1–500g, Storage cool and dry (-5 to 8 °C), Shelf life 2 years. The supplier suggests 100 to 1,000 parts per million, with a formulation pH between 3 and 8. In one supplier-recorded study, 17 women used a 0.05% test solution twice daily for 56 days. By day 56, measured facial line volume was 21.92% lower, and line area was 21.51% lower than baseline. Explore Acetyl Hexapeptide-8 for skincare designed to improve the appearance of fine lines. For cosmetic formulation development.

Editorial & Verification Scope Note:Note: In the first 2 seconds of the video, the automated voiceover/caption mispronounces "Acetyl Hexapeptide-8" as "Axonyl Hexapeptide-8"; the on-screen specification table at 00:06 correctly lists INCI: Acetyl Hexapeptide-8 (CAS 616204-22-9). Study figures reflect supplier-reported topical test solution data (0.05%, n = 17) for cosmetic formulation development only.

Carrier Delivery & Formulation Brief1:20

Delivery System Brief · Acetyl Hexapeptide-8 · 1:20

AHPX+ (Acetyl Hexapeptide-8 + Hydrolyzed Chitosan Carrier): Penetration & 28-Day Split-Face Study

Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).

Verification scope:Hydrolyzed chitosan peptide delivery concept (CN120248173A), preclinical penetration & GQI 28-day split-face data
Jump to timestamp:

Key Verifiable Points & Parameters

  • Delivery Architecture: Pairs Acetyl Hexapeptide-8 with a patent-pending hydrolyzed chitosan carrier (CN120248173A) designed to improve hydrophilic peptide transport across the stratum corneum.
  • Preclinical Fluorescence Penetration (Mouse Skin Model): Carrier formula showed +82% higher relative fluorescence at 2 hours and +219% (3.19×) higher at 8 hours compared with Acetyl Hexapeptide-8 alone.
  • 28-Day Split-Face Study Design (GQI, n = 33): 33 adult volunteers comparing a cream containing 1% AHPX+ against a comparator cream from Day 0 to Day 28.
  • Measured Day 28 Split-Face Outcomes: Crow’s-feet volume decreased by 38.49%, length decreased by 30.4%, and the Cutometer R2 gross elasticity parameter increased by 17.46% (~17.6% rounded in video) vs baseline on the 1% AHPX+ side.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).

Verbatim Audio / Visual Transcript:Meet AHPX+, a cosmetic ingredient system built around Acetyl Hexapeptide-8. Computational screening helped guide peptide selection. The selected peptide is paired with a hydrolyzed chitosan carrier. In a mouse skin model, the carrier formula showed higher relative fluorescence than the peptide alone at 2 and 8 hours (+82% at 2 h and +219% at 8 h vs peptide alone; supplier-reported preclinical data). Laboratory assays also explored the peptide’s molecular interactions. The supplier then conducted a 28-day half-face study with 33 adults comparing a cream containing 1% AHPX+ with a comparator cream. At day 28, measured crow’s-feet length fell 30.4%, while the R2 elasticity parameter rose 17.6% from baseline on the AHPX+ side. Explore AHPX+ for skincare designed to improve the appearance of fine lines and firmness. For cosmetic formulation development.

Editorial & Verification Scope Note:Preclinical fluorescence penetration and 28-day split-face figures reflect data for the tested 1% AHPX+ carrier formulation (n = 33, Guangzhou Quality Supervision & Testing Institute). Confirm whether your inquiry requires neat Acetyl Hexapeptide-8 powder (CAS 616204-22-9) or the 1,000 ppm AHPX+ carrier complex when requesting specifications and samples.

Scalp Care Active Brief1:05

Scalp-Care Formulation Brief · 1:05

Menthol Citrate Ester: Amphiphilic Scalp-Care Active Dispersion & In-Vitro Study Overview

Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.

Verification scope:Scalp-care co-formulation active, aqueous dispersion & supplier in-vitro test summary
Jump to timestamp:

Key Verifiable Points & Parameters

  • Chemistry & Structure: Synthesized via esterification of L-menthol with citric acid, combining a cooling menthol sensory profile with an amphiphilic structure.
  • Formulation Compatibility: Disperses more readily than free menthol in water-based and multi-phase scalp systems, including shampoos, scalp cleansing gels, and leave-on scalp sprays.
  • Supplier In-Vitro Contact Data (3-Minute Contact): A tested shampoo containing 1.5% to 2.0% Menthol Citrate Ester showed 90.59% (at 1.5%) to 95.29% (at 2.0%) inhibition of Malassezia furfur in laboratory testing.
  • Scalp-Care Co-Formulation Context: Evaluated alongside scalp-care actives such as Diaminopyrimidine Oxide (Aminexil) and Copper Tripeptide-1 (GHK-Cu) in OEM/ODM hair and scalp programs.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.

Verbatim Audio / Visual Transcript:A refreshing scalp care formula starts with the right ingredient. Menthol citrate ester is made by esterifying L-menthol with citric acid. It retains a fresh menthol sensation. Its amphiphilic structure helps it disperse in water-based and multi-phase formulations. Formulators can explore it in shampoos, scalp cleansing gels, and scalp sprays. In supplier laboratory testing, a shampoo with 1.5% to 2.0% menthol citrate ester showed 90.59% to 95.29% inhibition of Malassezia furfur after 3 minutes of contact (supplier-reported in-vitro data for the tested formula). Bring a clean cooling sensation to your next scalp care concept with menthol citrate ester. For cosmetic formulation development.

Editorial & Verification Scope Note:Menthol Citrate Ester is a non-peptide cosmetic scalp-care functional ester supported in WUMO / Suzhou Xilin scalp formulation programs. In-vitro Malassezia furfur inhibition figures apply only to the supplier-tested shampoo formula under 3-minute laboratory contact conditions and do not constitute an anti-dandruff drug or medical claim.

Frequently Asked Questions

Should our brand buy neat Acetyl Hexapeptide-8 powder or the AHPX+ (1,000 ppm) modified-chitosan liquid complex?

Choose neat lyophilized Acetyl Hexapeptide-8 powder (CAS 616204-22-9, within China’s YY/T 10004—2026 solid-powder scope; requires 2–8 °C storage) if your R&D lab builds its own encapsulation or anhydrous delivery vehicle. Choose AHPX+ (Acetyl Hexapeptide-8 Pro, CN120248173A) if you want a cold-processable (≤45 °C) aqueous delivery complex already validated for 3.19× (+219%) 8-hour skin permeation and 28-day human split-face crow’s-feet efficacy at 0.5%–5.0% w/w formula input.

Can Copper Tripeptide-1 (GHK-Cu) be combined with Vitamin C, Glycolic Acid, or EDTA in the same serum?

No—direct co-formulation in a single aqueous phase is strongly discouraged. Low pH (<4.5) protonates histidine and releases free Cu²⁺, L-ascorbic acid undergoes rapid copper-catalyzed oxidation, and strong chelators (disodium EDTA, caprylhydroxamic acid) strip copper out of the GHK complex. We formulate GHK-Cu at pH 5.5–6.8 with Ectoin, Panthenol, beta-glucan, and cross-linked hyaluronate instead.

Can you supply bulk compounded serum or cream bases in 5 kg–25 kg drums so we can fill bottles locally in the EU, US, or Latin America?

Yes. Bulk semi-finished cosmetic bases manufactured under Suzhou Xilin’s ISO 22716:2007 scope are a popular route for dermatology clinic groups and overseas brands that already have local filling partners—eliminating empty-bottle shipping volume, custom bottle mold delays, and finished-packaging import duties.

Start a Cosmetic Formulation or Active Compatibility Review

Share your target product format, active shortlist, pH/texture goals, and whether you need raw actives, bulk kg/L bases, or finished ODM.

Formulation Project Support & Active Selection Inquiry

Tell us what formula you are building, which co-actives (e.g., PHA, niacinamide, retinoids, Pro-Xylane, Ectoin) must coexist, and your target market.

If the embedded form does not load, email [email protected] with your formulation brief.

Email Instead